These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7475777)

  • 1. Randomised trialomania? The multicentre liver transplant trials of tacrolimus.
    Starzl TE; Donner A; Eliasziw M; Stitt L; Meier P; Fung JJ; McMichael JP; Todo S
    Lancet; 1995 Nov; 346(8986):1346-50. PubMed ID: 7475777
    [No Abstract]   [Full Text] [Related]  

  • 2. Tacrolimus (FK506) and the pharmaceutical/academic/regulatory gauntlet.
    Starzl TE; Todo S; Demetris AJ; Fung JJ
    Am J Kidney Dis; 1998 Jun; 31(6 Suppl 1):S7-14. PubMed ID: 9631858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus for prevention of liver allograft rejection: clinical trials and tribulations.
    Morris RE; Brown BW
    Lancet; 1995 Nov; 346(8986):1310-1. PubMed ID: 7475764
    [No Abstract]   [Full Text] [Related]  

  • 4. Tacrolimus is superior to cyclosporine in liver transplantation.
    Busuttil RW; Holt CD
    Transplant Proc; 1998 Aug; 30(5):2174-8. PubMed ID: 9723432
    [No Abstract]   [Full Text] [Related]  

  • 5. Tacrolimus in the prevention of graft rejection: new indication. Helpful alternative to ciclosporin.
    Prescrire Int; 1998 Aug; 7(36):108-9. PubMed ID: 10342948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus in transplant rejection.
    Rath T
    Expert Opin Pharmacother; 2013 Jan; 14(1):115-22. PubMed ID: 23228138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tacrolimus (FK 506) in kidney transplantation: five-year survival results of the U.S. multicenter, randomized, comparative trial.
    Vincenti F
    Transplant Proc; 2001; 33(1-2):1019-20. PubMed ID: 11267172
    [No Abstract]   [Full Text] [Related]  

  • 9. Tacrolimus and ciclosporin microemulsion in renal transplantation.
    Emovon OE; Browne BJ
    Lancet; 2002 Sep; 360(9335):799; author reply 800-1. PubMed ID: 12241844
    [No Abstract]   [Full Text] [Related]  

  • 10. The current status of hepatic transplantation at the University of Pittsburgh.
    Abu-Elmagd K; Fung J; Todo S; Rao A; Reyes J; Demetris J; Mazariegos G; Fontes P; McMichael J; Furukawa H
    Clin Transpl; 1995; ():145-70. PubMed ID: 8794262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-year follow-up of the European Multicenter Tacrolimus (FK506) Liver Study.
    Pichlmayr R; Winkler M; Neuhaus P; McMaster P; Calne R; Otto G; Williams R; Groth CG; Bismuth H
    Transplant Proc; 1997 Aug; 29(5):2499-502. PubMed ID: 9270825
    [No Abstract]   [Full Text] [Related]  

  • 12. Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients.
    Webster A; Woodroffe RC; Taylor RS; Chapman JR; Craig JC
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003961. PubMed ID: 16235347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lessons learnt from the multicentre randomized trials of tacrolimus in liver transplantation.
    Soin AS; Jamieson NV
    Natl Med J India; 1996; 9(5):224-6. PubMed ID: 8937063
    [No Abstract]   [Full Text] [Related]  

  • 14. Belatacept for kidney transplant recipients.
    Masson P; Henderson L; Chapman JR; Craig JC; Webster AC
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD010699. PubMed ID: 25416857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation.
    Yussim A; Shaharabani E; Mor E; Lustig S; Bar-Nathan N; Shmueli D; Sobolev V; Dorfman B; Or H; Shapira Z
    Transplant Proc; 1996 Dec; 28(6):3178-9. PubMed ID: 8962233
    [No Abstract]   [Full Text] [Related]  

  • 16. Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients.
    Penninga L; Penninga EI; Møller CH; Iversen M; Steinbrüchel DA; Gluud C
    Cochrane Database Syst Rev; 2013 May; (5):CD008817. PubMed ID: 23728681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.
    Klintmalm GB; Goldstein R; Gonwa T; Wiesner RH; Krom RA; Shaw BW; Stratta R; Ascher NL; Roberts JW; Lake J
    Transplant Proc; 1993 Feb; 25(1 Pt 1):641-3. PubMed ID: 7679828
    [No Abstract]   [Full Text] [Related]  

  • 18. Belatacept (Nulojix) for prevention of renal transplant rejection.
    Med Lett Drugs Ther; 2011 Dec; 53(1379-1380):98-9. PubMed ID: 22173428
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of cyclosporine A and FK506 with regard to complaints and psychosocial characteristics before and after liver transplantation.
    Scholler G; Rose M; Neuhaus R; Neuhaus P; Klapp BF
    Transplant Proc; 1997 Aug; 29(5):2491-3. PubMed ID: 9270822
    [No Abstract]   [Full Text] [Related]  

  • 20. Tacrolimus and ciclosporin microemulsion in renal transplantation.
    Bruijn JA; van der Woude FJ
    Lancet; 2002 Sep; 360(9335):800; author reply 800-1. PubMed ID: 12241846
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.